Effect of Tesofensine on Weight Reduction in Patients With Obesity.

NCT00394667 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-04-22

No results posted yet for this study

Summary

Purpose:

To evaluate the efficacy on weight reduction, metabolic parameters and safety of tesofensine versus placebo in obese patients

Conditions

Interventions

DRUG

Tesofensine

Sponsors & Collaborators

  • NeuroSearch A/S

    lead INDUSTRY

Principal Investigators

  • Arne V Astrup, MD · Department of Human Nutrition, The Royal Veterinary & Agricultural University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2007-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394667 on ClinicalTrials.gov